Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic disease of the joints that can cause a disabling degree of pain and significantly interfere with an individual’s day-to-day living.

What is Rheumatoid Arthritis?

Rheumatoid arthritis or RA is an inflammatory condition that affects joints primarily leading to pain and stiffness and difficulty in movements. Commonly affected joints are those of the hands, feet and wrists. RA however can also affect other parts of the body.

What Causes Rheumatoid Arthritis?

Rheumatoid Arthritis Symptoms

Rheumatoid Arthritis Diagnosis

Are There Any Natural Remedies for Rheumatoid Arthritis?

Rheumatoid Factor Test

Knee Rheumatoid Arthritis

Total Knee Replacement and Rheumatoid Arthritis

Hip Rheumatoid Arthritis

Rheumatoid Arthritis and Feet

Rheumatoid Arthritis and Pregnancy

Rheumatoid Arthritis, Family Planning & Pregnancy

See more featured articles »

Rheumatoid Arthritis and Gum Disease

Rheumatoid Arthritis and Depression

Rheumatoid Arthritis and Gout

Juvenile Rheumatoid Arthritis

Juvenile Rheumatoid Arthritis Symptoms

Juvenile Rheumatoid Arthritis Types

Juvenile Rheumatoid Arthritis Diagnosis

Juvenile Rheumatoid Arthritis Treatment

Rheumatoid Arthritis Nodules

Rheumatoid Arthritis and Winter Weather

Rheumatoid Arthritis Treatment

Disease-Modifying AntiRheumatic Drugs (DMARDs)

Rheumatoid Arthritis Management

Radiotherapy and Rheumatoid Arthritis

Rheumatoid Arthritis and Acupuncture

Yoga and Tai chi in Rheumatoid Arthritis

Rheumatoid Arthritis and Exercise

Rheumatoid Arthritis Diet and Nutrition

Self-Help and Living with Rheumatoid Arthritis

Rheumatoid Arthritis Research

Rheumatoid Arthritis Support

Rheumatoid Arthritis Prognosis

Rheumatoid Arthritis Complications

Rheumatoid Arthritis Epidemiology

Rheumatoid Arthritis Skin Problems

Rheumatoid Arthritis History

Causes of Hand Pain

Rheumatoid Arthritis and Vitamin D

Psoriatic Arthritis vs Rheumatoid Arthritis

Can Antibiotics Increase the Risk of Arthritis?

Latest Rheumatoid Arthritis News and Research

Understanding the complex spectrum of Castleman disease

Castleman disease (CD) is a rare, non-clonal lymphoproliferative disorder that manifests with a wide range of histologic and clinical features.

11 Apr 2025

Refining the diagnosis of large granular lymphocytic leukemias and their mimics

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal proliferation of cytotoxic lymphocytes. Among them, T-cell LGLL (T-LGLL) and NK-cell LGLL (NK-LGLL) are the most prominent.

10 Apr 2025

Study reveals brain circuit behind apathy in advanced cancer

The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the unavoidable consequences of their declining physical health and extreme weight loss.

10 Apr 2025

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions.

9 Apr 2025

Breakthrough nanoparticle delivery method targets brain inflammation for multiple conditions

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease, multiple sclerosis, Parkinson's disease and cancer cachexia.

9 Apr 2025

Breakthrough research identifies small peptide for psoriasis treatment

Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream.

3 Apr 2025

Annual COVID-19 boosters crucial for immunocompromised individuals

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.

1 Apr 2025

Machine learning identifies key comorbidities predicting premature death in IBD patients

Researchers use machine learning models to investigate patterns between multimorbidity and premature deaths among decedents with irritable bowel disease.

28 Mar 2025

Study explores how sex chromosomes and hormones influence immune responses

Women have a higher proportion of key immune cells between puberty and menopause, which may be linked to the sex hormone estrogen and explain why they are less susceptible to certain infectious diseases than men, according to a new study led by researchers at UCL.

27 Mar 2025

COVID-derived molecular mimics may be involved in triggering autoimmunity

COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes.

26 Mar 2025

City of Hope researchers uncover the two-step process of tumor formation

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have found that cell mutations are necessary but not always sufficient for tumors to form.

26 Mar 2025

Arthritis drug shows promise in halting seizures in mice with epilepsy

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin–Madison.

25 Mar 2025

New research paves the way for non-hormonal endometriosis treatments

Roughly 200 million women around the world suffer from endometriosis, a condition that causes tissue from the lining of the uterus to grow in places outside of the uterus.

22 Mar 2025

Harnessing AI to combat rheumatoid arthritis

Fan Zhang, PhD, sees artificial intelligence as a pathway to finding an effective way to combat an intractable enemy: rheumatoid arthritis.

18 Mar 2025

IL-12 targeting could open pathways for new Alzheimer's treatments

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease.

17 Mar 2025

Experts release new guidelines on JAK inhibitors for chronic inflammatory diseases

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

17 Mar 2025

Innovative gel prevents post-surgery adhesions in animal models

Surgical adhesions - common, sometimes life-threatening complications that arise after open or laparoscopic abdominal surgery - can be prevented in mice and pigs by a gel impregnated with a molecule that blocks a key signaling pathway in the formation of scar tissue.

12 Mar 2025

Natural ingredient gluconolactone offers hope for targeted lupus therapy

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and damaging organs.

12 Mar 2025

Misdiagnosis of autoimmune diseases leads to long-term patient impact

A 'chasm of misunderstanding and miscommunication' is often experienced between clinicians and patients, leading to autoimmune diseases such as lupus and vasculitis being wrongly diagnosed as psychiatric or psychosomatic conditions, with a profound and lasting impact on patients, researchers have found.

4 Mar 2025

Epstein-Barr virus infection predisposes people to develop Crohn's disease

Crohn's disease, a debilitating inflammatory bowel disease, has many known contributing factors, including bacterial changes in the microbiome that foster an inflammatory environment.

3 Mar 2025